Titan Medical Announces Purchase Order from Medtronic

Titan Medical Inc. | May 04, 2022

Titan Medical

Titan Medical Inc. a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery announced receipt of a $2.6 million purchase order from Medtronic plc a global leader in healthcare technology.

The order covers the purchase of instruments and cameras that will be used in preclinical activities and the evaluation of Titan Medical as a potential manufacturing and supply partner for Medtronic.

Medtronic has been a great partner for Titan since 2020 and we’re excited about this opportunity to further our work together. Our manufacturing team and capabilities continue to expand at our operations in Chapel Hill. With this order, we will produce instruments and cameras for Medtronic’s evaluation and testing in addition to producing instruments and cameras for our own single-access RAS platform, Enos.”

Paul Cataford, Interim President and CEO of Titan

For clarity, these agreements are between Medtronic and Titan Medical Inc. Titan Medical is not affiliated with Titan Spine, which Medtronic acquired in 2019.

About Titan Medical

Titan Medical Inc. a medical device company headquartered in Toronto, Ontario, with operations in Chapel Hill, North Carolina, is focused on enhancing robotic-assisted surgery (RAS) using innovative technology through a single access point. The Enos™ robotic single access surgical system is being developed with an ergonomic focus to provide a surgical experience that imitates real-life movements that surgeons demand. The Enos system includes multi-articulating instruments designed to allow surgeons an increased range of motion in a confined space, with dexterity and the ability to exert the forces necessary to complete common surgical tasks. Titan intends to initially pursue gynecologic surgical indications with the Enos


As the number of patients with acute and chronic respiratory conditions rises, how will your department address the ongoing respiratory therapy staffing shortage? More than 92,000 RTs are expected to leave the profession by 2030, while enrollment in respiratory care education has declined 27% since 2010.* What impact will this h


As the number of patients with acute and chronic respiratory conditions rises, how will your department address the ongoing respiratory therapy staffing shortage? More than 92,000 RTs are expected to leave the profession by 2030, while enrollment in respiratory care education has declined 27% since 2010.* What impact will this h

Related News


InterSystems Launches HealthShare® Health Connect Cloud™ in AWS Marketplace

Businesswire | May 23, 2023

InterSystems, a creative data technology provider dedicated to helping customers solve the most critical scalability, interoperability, and speed problems, today announced that HealthShare® Health Connect Cloud™, a high-performance healthcare integration engine, is available in AWS Marketplace. AWS Marketplace is a digital catalog with thousands of software listings from independent software vendors that make it easy to find, test, buy, and deploy software that runs on Amazon Web Services (AWS). HealthShare Health Connect Cloud is a scalable solution, serving the needs of healthcare delivery systems of all sizes – from small clinics to the world's largest and most complex systems. With its availability in AWS Marketplace, customers can benefit from improved data automation and management capabilities, leading to enhanced patient outcomes. AWS customers can now access HealthShare Health Connect Cloud's platform-as-a-service (PaaS) offerings directly in AWS Marketplace. The PaaS solution delivers managed healthcare integration cloud services, providing high-volume transaction support, process management, and monitoring to support mission-critical applications. With a simplified procurement process that includes flexible contract models, improved governance and control, license management and renewals, and custom pricing and terms, AWS customers can easily deploy HealthShare Health Connect Cloud and begin scaling data-driven applications on the cloud. “Our operating system for health at home and integration with HealthShare HealthConnect Cloud allows healthcare organizations to deliver health-at-home, value-based care for the Medicare population,” said Ainar Abdrakhmanov, CEO, Pria. “With expanded accessibility and access to cloud-based, data-driven applications in AWS Marketplace, we can accelerate data automation and management capabilities to advance our mission of transforming chronic care management.” “With HealthShare Health Connect Cloud in AWS Marketplace, we can extend our reach to hundreds of thousands of cloud-ready customers, powering accelerated healthcare data integration and true interoperability,” said Todd Sylvester, Director of Cloud Strategy, Execution, and Alliances of InterSystems. “At InterSystems, we streamline purchasing and onboarding to better support customers in their shift to the cloud and a digital-first healthcare approach.” HealthShare Health Connect Cloud is now generally available in AWS Marketplace. For more information on InterSystems and its healthcare integration solutions About InterSystems Established in 1978, InterSystems is the leading provider of next-generation solutions for enterprise digital transformations in the healthcare, finance, manufacturing, and supply chain sectors. Its cloud-first data platforms solve interoperability, speed, and scalability problems for large organizations around the globe. InterSystems is committed to excellence through its award-winning, 24×7 support for customers and partners in more than 80 countries. Privately held and headquartered in Cambridge, Massachusetts, InterSystems has 37 offices in 26 countries worldwide

Read More


Cumulus Neuroscience Lands Coveted iF Design and Red Dot Awards for Innovative At-Home EEG Device

Prnewswire | April 28, 2023

Cumulus Neuroscience a global digital health company, focused on advancing neuroscience clinical trials and patient care through improved data, has been named a 2023 iF Design Award and 2023 Red Dot recipient for the product design of its first-in-class EEG headset. A key component of the Cumulus Platform, the current version of the dry-sensor EEG headset was designed by PA Consulting as an elegant solution for obtaining clinical-grade data in remote settings to monitor and evaluate neurological activity. "We started Cumulus with the goal of uncovering insights that would lead to better treatment and diagnosis of neuropsychiatric and neurodegenerative conditions – and an essential part of that mission is an easy-to-use, reliable and sophisticated EEG Headset," said Brian Murphy, Founder and Chief Scientific Officer, Cumulus Neuroscience. "This recognition from iF Design and Red Dot is particularly gratifying because not only is the design beautifully crafted, but the headset also has the power to help improve the lives of millions of patients living with these debilitating conditions." The iF Design Award has come to symbolize the stamp of quality for excellent design. Additionally, the globally recognized Red Dot Award is presented to those who demonstrate quality design and dedication. "The importance of EEG-synced data in precision CNS drug development is growing, and thus the ability to capture real-world data in clinical trials reliably – especially from patients participating in those trials remotely, from their own homes – is critical for biopharma innovators seeking to accelerate their programs," said Aman Bhatti, MD, CEO, Cumulus Neuroscience. "These two awards are a testament to our team's dedication to developing patient-centered solutions that both enable the capture of high-quality data, and prioritize ease-of-use and comfort for patients and caregivers." The Cumulus Platform combines the EEG headset with an at-home neuro-assessment platform design, which can track the integrity and connectivity of brain networks. The headset synchronizes with tablet-based functional assessments for use in-clinic or unsupervised environments, allowing for increased ease-of-use for patients, caregivers and clinical teams. By enabling remote monitoring of patients across multiple domains of brain function, researchers conducting clinical trials are able to sample a broad spectrum of CNS domain measurements, in order to understand the effects of certain treatments on cognition, mood, memory, and language, in order to better match the right patient to the right therapy. Cumulus continues to advance its EEG Headset and data platform, providing major biopharma partners and collaborators with a suite of state-of-the-art tools to help advance the discovery and development of new medicines for neuropsychiatric and neurodegenerative conditions. About Cumulus Neuroscience With a mission to generate the data and insights required to accelerate diagnosis and management of central nervous system (CNS) disorders for millions of patients and caregivers around the world, Cumulus Neuroscience is advancing an AI-based, multi-domain digital biomarker platform to enable better, faster decision making in neurology and neuropsychiatry clinical trials and patient care. Designed for and with 10 of the world's leading pharma companies, the platform enables decentralised trials, and is already making a difference in the development of therapies for Alzheimer's Disease, depression and schizophrenia.

Read More


CharmHealth Democratizes Generative AI Use Across Clinical Workflows in Healthcare Establishments and Verticals

Businesswire | May 04, 2023

CharmHealth, a leading cloud-based health IT platform for healthcare establishments and health verticals, announced the integration of large language model AI/GPT within medical provider and staff workflows to bring the power of cutting-edge natural language processing to the fingertips of busy providers and medical staff. Increasing productivity and automating tedious tasks has always been the goal of the CharmHealth platform. Now, with the availability of GPT-3 through an API framework, a state-of-the-art conversational AI model is available to CharmHealth users to enhance global clinical efficiency. Enhancing efficiencies in the clinic’s workflow directly impacts the quality of patient care and provider job satisfaction. CharmHealth integrates search and summarize features, including auto-generating chart note components, note summaries, referral letters, lab result queries, and other features. Clinical virtual assistant features such as auto-suggestion of diagnosis codes and treatment plans are also being rolled out. “Physicians throughout the nation suffer unprecedented levels of burnout, heightened by the pandemic. CharmHealth’s GPT integration is aimed at alleviating tedious tasks, increasing accuracies and efficiencies using advanced technological solutions, and restoring the joy of practicing medicine and helping people,” said Pramila Srinivasan, Ph.D., CEO of CharmHealth. “This launch reiterates our commitment to bringing innovation to the point of care and improving patient outcomes.” The seamless integration of GPT in CharmHealth EHRs will empower physicians to focus on what they do best: providing patients with the best care. By enhancing the adoption of conversational AI in healthcare, this integration can potentially improve patient outcomes while reducing costs. In addition to tools for healthcare providers, CharmHealth also brings efficiency and accuracy into coding and revenue cycle management by integrating GPT prompts into the provider and biller workflows. Auto-suggestion of CPT codes and search capabilities within chart notes are designed to mitigate the complexity and tedium of manual coding and billing. CharmHealth plans further enhancements in the use of AI in the areas of navigation, patient queries, appointments, a robust auto-suggesting virtual assistant, transcription, translation to multiple languages, high-risk patient identification, and prediction of clinical course. MedicalMine Inc. is committed to judiciously utilizing the potential of AI in its CharmHealth suite of products. About CharmHealth is a cloud-first platform created by California-based MedicalMine Inc., a leading health-IT platform for healthcare establishments and verticals. CharmHealth’s mission is to bring innovation to the point of care, thus enabling quality healthcare for all. CharmHealth includes electronic health records, practice management, a patient portal for patient engagement, revenue cycle management, telehealth solutions, and an instant messaging solution for providers, all with complementary mobile solutions

Read More